Abstract

BackgroundCompound Muniziqi granule (MNZQ) is a multi-component herbal preparation and a popular traditional Uighur medicine used in China for treating endocrine disorder-induced acne, chloasma, dysmenorrhea, menopausal syndrome, and melanoma. Harmine presented in MNZQ has been confirmed potential anticancer effect on the B16 cells among others. The purpose of this study is to explore the inhibitory effects of MNZQ against B16 cells and mechanism of autophagy and apoptosis induced by harmine in B16 cells.MethodsThe cell viability was calculated by CCK8 assay. The in vitro tyrosinase activity was determined by spectrophotometry. The harmine-induced autophagy was demonstrated by electron microscopy and MDC staining. Flow cytometry was used to measure cell death and cell cycle distribution. All proteins expression was assessed by western blot.ResultsMNZQ and some herb extracts contained in preparation displayed inhibitory effects on B16 cells but without inhibition on mushroom tyrosinase compared with kojic acid. The formation of autophagosome was markedly induced by harmine with the accretion of LC3-II and the degeneration of p62 in B16 cells, which indicated that harmine was an autophagy inducer. Cell death and sub-G2 population suggested that harmine could induce cell death. Particularly, 3-MA, an autophagy inhibitor, was discovered to prevent harmine-induced decrease of the cell viability and cell cycle arrest on G2 phase, indicating that autophagy was vital to the cell death. In addition, the results indicated that harmine could inhibit the phosphorylation of Akt and mTOR, which might mediate autophagy.ConclusionHarmine could induce autophagy and apoptosis by inhibiting Akt/mTOR pathway in B16 cells. Harmine might be a promising therapeutic agent for treatment of melanoma in MNZQ.

Highlights

  • Compound Muniziqi granule (MNZQ) is a multi-component herbal preparation and a popular traditional Uighur medicine used in China for treating endocrine disorder-induced acne, chloasma, dysmenorrhea, menopausal syndrome, and melanoma

  • Primary antibodies of GAPDH, Microtubule-associated protein1 light chain 3 (LC3), P62, Mammalian target of rapamycin (mTOR), p-mTOR, Akt, p-Akt, ERK1/2, p-ERK1/2 were purchased from Cell Signaling Technology (Danvers, MA)

  • This study showed that MNZQ could display potential inhibitory effects on B16 cells but not affect tyrosinase activity

Read more

Summary

Introduction

Compound Muniziqi granule (MNZQ) is a multi-component herbal preparation and a popular traditional Uighur medicine used in China for treating endocrine disorder-induced acne, chloasma, dysmenorrhea, menopausal syndrome, and melanoma. Compound Muniziqi granule (MNZQ), recorded in Pharmaceutical Standards-Uighur Medicine and the Ministry of Health of the People’s Republic of China, is a multicomponent herbal preparation and a popular traditional Uighur medicine (TUM) used in China [3]. Study has showed that hormone synthesis and metabolism can be effectively regulated by treating with MNZQ. What is more, it can treat endocrine disorder-induced acne, chloasma, dysmenorrhea, menopausal syndrome, and melanoma [4]. It has become a focus to search for new drugs from folk medicine which could inhibit tyrosinase activity and decrease the proliferation of melanoma cell

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call